- Home
- SLRX vs ESTA Comparison
SLRX vs ESTA Comparison
Compare SLRX & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLRX | ESTA |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | Costa Rica |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 2.1B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SLRX | ESTA |
|---|---|---|
| Price | $0.80 | $73.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $74.29 |
| AVG Volume (30 Days) | ★ 948.2K | 426.0K |
| Earning Date | 11-14-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $190,973,000.00 |
| Revenue This Year | N/A | $29.25 |
| Revenue Next Year | N/A | $24.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.76 |
| 52 Week Low | $0.71 | $26.56 |
| 52 Week High | $108.00 | $73.50 |
Technical Indicators
Market Signals| Indicator | SLRX | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 26.54 | 74.04 |
| Support Level | $0.78 | $62.77 |
| Resistance Level | $0.89 | $69.69 |
| Average True Range (ATR) | 0.07 | 3.03 |
| MACD | 0.10 | -0.21 |
| Stochastic Oscillator | 9.51 | 100.00 |
Price Performance
Historical ComparisonAbout SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.